Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $450.00 | 3 | 89.0% |
| Food and Beverage | $55.62 | 3 | 11.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| COMSORT, Inc | $450.00 | 3 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $55.62 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $150.00 | 1 | COMSORT, Inc ($150.00) |
| 2017 | $355.62 | 5 | COMSORT, Inc ($300.00) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/09/2018 | COMSORT, Inc | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2017 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: ONCOLOGY | ||||||
| 08/03/2017 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2017 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: ONCOLOGY | ||||||
| 03/28/2017 | COMSORT, Inc | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: ONCOLOGY | ||||||
| 03/28/2017 | COMSORT, Inc | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $100.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 24 | 1,102 | 1,535 | $109,513 | $31,348 |
| 2020 | 54 | 3,724 | 36,394 | $1.1M | $298,000 |
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 3 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 39 | 181 | $10,329 | $2,280 | 22.1% |
| 86304 | Immunologic analysis for detection of tumor antigen | Office | 2020 | 20 | 106 | $7,314 | $2,186 | 29.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 17 | 19 | $5,732 | $1,870 | 32.6% |
| 84550 | Uric acid level, blood | Office | 2020 | 102 | 414 | $6,210 | $1,851 | 29.8% |
| 84100 | Phosphate level | Office | 2020 | 86 | 374 | $5,984 | $1,753 | 29.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2020 | 79 | 95 | $5,320 | $1,565 | 29.4% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 130 | 184 | $4,048 | $1,175 | 29.0% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2020 | 16 | 39 | $3,748 | $999.96 | 26.7% |
| 84153 | Psa (prostate specific antigen) measurement | Office | 2020 | 18 | 53 | $3,233 | $966.90 | 29.9% |
| J9263 | Injection, oxaliplatin, 0.5 mg | Office | 2020 | 12 | 8,500 | $8,500 | $920.34 | 10.8% |
| J9190 | Injection, fluorouracil, 500 mg | Office | 2020 | 14 | 340 | $2,040 | $431.02 | 21.1% |
| 84439 | Thyroxine (thyroid chemical) measurement | Office | 2020 | 35 | 45 | $1,350 | $396.73 | 29.4% |
| J0640 | Injection, leucovorin calcium, per 50 mg | Office | 2020 | 13 | 158 | $1,580 | $374.79 | 23.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 22 | 26 | $1,170 | $344.90 | 29.5% |
| 84481 | Thyroid hormone, t3 measurement | Office | 2020 | 16 | 20 | $1,120 | $337.10 | 30.1% |
| 85610 | Blood test, clotting time | Office | 2020 | 12 | 79 | $1,027 | $336.75 | 32.8% |
| 82248 | Bilirubin level | Office | 2020 | 18 | 47 | $799.00 | $233.94 | 29.3% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation | Office | 2020 | 36 | 57 | $741.00 | $233.37 | 31.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 11 | 12 | $684.00 | $226.00 | 33.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2020 | 29 | 1,830 | $9,150 | $179.11 | 2.0% |
| 82787 | Gammaglobulin (immune system protein) measurement | Office | 2020 | 12 | 22 | $594.00 | $172.92 | 29.1% |
| 83550 | Iron binding capacity | Office | 2020 | 16 | 17 | $493.00 | $147.39 | 29.9% |
| 85045 | Red blood count, automated test | Office | 2020 | 26 | 34 | $442.00 | $132.18 | 29.9% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2020 | 14 | 25 | $425.00 | $121.94 | 28.7% |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | Office | 2020 | 11 | 570 | $570.00 | $113.50 | 19.9% |
About Dr. Daniel Lieber, M.D
Dr. Daniel Lieber, M.D is a Hematology & Oncology healthcare provider based in North Conway, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356454623.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Lieber, M.D has received a total of $505.62 in payments from pharmaceutical and medical device companies, with $150.00 received in 2018. These payments were reported across 6 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($450.00).
As a Medicare-enrolled provider, Lieber has provided services to 4,826 Medicare beneficiaries, totaling 37,929 services with total Medicare billing of $329,348. Data is available for 2 years (2020–2021), covering 78 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology, Hematology & Oncology
- Location North Conway, NH
- Active Since 08/17/2006
- Last Updated 01/10/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1356454623
Products in Payments
- KEYTRUDA (Biological) $450.00
- AFINITOR (Drug) $55.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.